Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia

Am J Obstet Gynecol. 2009 Mar;200(3):305.e1-6. doi: 10.1016/j.ajog.2009.01.020.

Abstract

Objective: We hypothesized that pretreatment with docosahexaenoic acid (DHA), a potentially neuroprotective polyunsaturated fatty acid, would improve function and reduce brain damage in a rat model of perinatal hypoxia-ischemia.

Study design: Seven-day-old rats were divided into 3 treatment groups that received intraperitoneal injections of DHA 1, 2.5, or 5 mg/kg as DHA-albumin complex and 3 controls that received 25% albumin, saline, or no injection. Subsequently, rats underwent right carotid ligation followed by 90 minutes of 8% oxygen. Rats underwent sensorimotor testing (vibrissae-stimulated forepaw placing) and morphometric assessment of right-sided tissue loss on postnatal day 14.

Results: DHA pretreatment improved forepaw placing response to near-normal levels (9.5 +/- 0.9 treatment vs 7.1 +/- 2.2 controls; normal = 10; P < .0001). DHA attenuated hemisphere damage compared with controls (P = .0155), with particular benefit in the hippocampus with 1 mg/kg (38% protection vs albumin controls).

Conclusion: DHA pretreatment improves functional outcome and reduces volume loss after hypoxia-ischemia in neonatal rats.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Animals, Newborn
  • Body Temperature
  • Body Weight
  • Disease Models, Animal
  • Docosahexaenoic Acids / pharmacology*
  • Female
  • Hypoxia-Ischemia, Brain / drug therapy*
  • Hypoxia-Ischemia, Brain / pathology
  • Injections, Intraperitoneal
  • Male
  • Neuroprotective Agents / pharmacology*
  • Physical Stimulation
  • Pregnancy
  • Prenatal Exposure Delayed Effects / pathology
  • Prenatal Exposure Delayed Effects / prevention & control*
  • Rats
  • Rats, Wistar
  • Vibrissae / physiology

Substances

  • Neuroprotective Agents
  • Docosahexaenoic Acids